Ładuje się......
Considerations for interactions of drugs used for the treatment of COVID-19 with anti-cancer treatments
SARS-CoV2 infection is an emerging issue worldwide. Cancer patient are at increased risk of infection compared to general population. On the other hand, these patients are at major risk of drug interactions caused by renal and hepatic impairment background. Because of the long-term use of chemothera...
Zapisane w:
| Wydane w: | Crit Rev Oncol Hematol |
|---|---|
| Główni autorzy: | , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Elsevier B.V.
2020
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7217119/ https://ncbi.nlm.nih.gov/pubmed/32460133 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.critrevonc.2020.102982 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|